{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:02:29Z","timestamp":1793325749278,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:00:00Z","timestamp":1568332800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:00:00Z","timestamp":1568332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009879","name":"Regione Emilia-Romagna","doi-asserted-by":"publisher","award":["Ricerca Regione-Universit\u00e0 2007\u20132009"],"award-info":[{"award-number":["Ricerca Regione-Universit\u00e0 2007\u20132009"]}],"id":[{"id":"10.13039\/501100009879","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007109","name":"Universit\u00e0 degli Studi di Ferrara","doi-asserted-by":"publisher","award":["Fondo per l\u2019incentivazione alla Ricerca FIR 2017"],"award-info":[{"award-number":["Fondo per l\u2019incentivazione alla Ricerca FIR 2017"]}],"id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Autosomal dominant polycystic kidney disease (ADPKD) is mainly characterised by the development and enlargement of renal cysts that lead to end-stage renal disease (ESRD) in adult patients. Other clinical manifestations of this pathology include hypertension, haematuria, abdominal pain, cardiovascular system alterations and intracranial aneurysms. ADPKD is linked to mutations in either <jats:italic>PKD1<\/jats:italic> or <jats:italic>PKD2<\/jats:italic> that codifies polycystin-1 (PC1) and polycystin-2 (PC2 or TRPP2), respectively. PC1 and TRPP2 are membrane proteins that function as receptor-channel elements able to regulate calcium homeostasis. The function of polycystins has been mainly studied in kidney cells; but the role of these proteins in T lymphocytes is not well defined.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>T lymphocytes were produced from ADPKD1 and ADPKD2 patients as well as from non-ADPKD subjects undergoing renal replacement therapy (RRT) and healthy controls. Protein expression and phosphorylation levels were analysed by western blotting, cell proliferation was calculated by direct counting using trypan blue assay and intracellular calcium concentration was measured by Fura-2 method.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p><jats:italic>PKD2<\/jats:italic> mutations lead to the significant reduction of TRPP2 expression in T lymphocytes derived from ADPKD patients. Furthermore, a smaller TRPP2 truncated protein in T lymphocytes of patients carrying the mutation R872X in <jats:italic>PKD2<\/jats:italic> was also observed, suggesting that TRPP2 mutated proteins may be stably expressed. The silencing or mutation of <jats:italic>PKD2<\/jats:italic> causes a strong reduction of ATP-evoked calcium in Jurkat cells and ADPKD2 T lymphocytes, respectively. Moreover, T lymphocytes derived from both ADPKD1 and ADPKD2 patients show increased cell proliferation, basal chemotaxis and cell aggregation compared with T lymphocytes from non-ADPKD subjects. Similarly to observations made in kidney cells, mutations in <jats:italic>PKD1<\/jats:italic> and <jats:italic>PKD2<\/jats:italic> dysregulate ERK, mTOR, NFkB and MIF pathways in T lymphocytes.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Because the alteration of ERK, mTOR, NFkB and MIF signalling found in T lymphocytes of ADPKD patients may contribute to the development of interstitial inflammation promoting cyst growth and kidney failure (ESRD), the targeting of inflammasome proteins could be an intriguing option to delay the progression of ADPKD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-019-1540-6","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T04:31:08Z","timestamp":1568349068000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes"],"prefix":"10.1186","volume":"20","author":[{"given":"Riccardo","family":"Magistroni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Mangolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Guzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario R.","family":"Rapan\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Mignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"di Virgilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0007-0805","authenticated-orcid":false,"given":"Gianluca","family":"Aguiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,13]]},"reference":[{"key":"1540_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000346812","volume":"37","author":"G Aguiari","year":"2013","unstructured":"Aguiari G, Catizone L, Del Senno L. Multidrug therapy for polycystic kidney disease: a review and perspective. Am J Nephrol. 2013;37:175\u201382.","journal-title":"Am J Nephrol"},{"key":"1540_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3949\/ccjm.84a.16107","volume":"84","author":"V Krishnappa","year":"2017","unstructured":"Krishnappa V, Vinod P, Deverakonda D, Raina R. Autosomal dominant polycystic kidney disease and the heart and brain. Cleve Clin J Med. 2017;84:471\u201381.","journal-title":"Cleve Clin J Med"},{"key":"1540_CR3","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.ekir.2017.05.014","volume":"2","author":"FT Chebib","year":"2017","unstructured":"Chebib FT, Hogan MC, El-Zoghby ZM, et al. Autosomal dominant polycystic kidney patients may be predisposed to various cardiomyopathies. Kidney Int Rep. 2017;2:913\u201323.","journal-title":"Kidney Int Rep"},{"key":"1540_CR4","volume-title":"Polycystic kidney disease","author":"FM Ferreira","year":"2015","unstructured":"Ferreira FM, Watanabe EH, Onuchic LF. Polycystins and molecular basis of autosomal dominant polycystic kidney disease. In: Li X, editor. Polycystic kidney disease. Brisbane: Codon Publications; 2015. Chapter 7."},{"key":"1540_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/ncb754","volume":"4","author":"P Koulen","year":"2002","unstructured":"Koulen P, Cai Y, Geng L, et al. Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol. 2002;4:191\u20137.","journal-title":"Nat Cell Biol"},{"key":"1540_CR6","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1096\/fj.03-0687fje","volume":"18","author":"G Aguiari","year":"2004","unstructured":"Aguiari G, Banzi M, Gessi S, et al. Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells. FASEB J. 2004;18:884\u20136.","journal-title":"FASEB J"},{"key":"1540_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ceca.2017.05.011","volume":"69","author":"FO Lemos","year":"2018","unstructured":"Lemos FO, Ehrlich BE. Polycystin and calcium signaling in cell death and survival. Cell Calcium. 2018;69:37\u201345.","journal-title":"Cell Calcium"},{"key":"1540_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/1573402111309010007","volume":"9","author":"S Rossetti","year":"2013","unstructured":"Rossetti S, Harris PC. The genetics of vascular complications in autosomal dominant polycystic kidney disease (ADPKD). Curr Hypertens Rev. 2013;9:37\u201343.","journal-title":"Curr Hypertens Rev"},{"key":"1540_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ceca.2017.05.005","volume":"66","author":"T Busch","year":"2017","unstructured":"Busch T, K\u00f6ttgen M, Hofherr A. TRPP2 ion channels: critical regulators of organ morphogenesis in health and disease. Cell Calcium. 2017;66:25\u201332.","journal-title":"Cell Calcium"},{"key":"1540_CR10","volume-title":"Polycystic kidney disease","author":"A Karihaloo","year":"2015","unstructured":"Karihaloo A. Role of inflammation in polycystic kidney disease. In: Li X, editor. Polycystic kidney disease. Brisbane: Codon Publications; 2015. Chapter 14."},{"key":"1540_CR11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/1744-9987.12458","volume":"20","author":"I Kocyigit","year":"2016","unstructured":"Kocyigit I, Sener EF, Taheri S, et al. Toll-like receptors in the progression of autosomal dominant polycystic kidney disease. Ther Apher Dial. 2016;20:615\u201322.","journal-title":"Ther Apher Dial"},{"key":"1540_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1681\/ASN.2004121146","volume":"17","author":"B Pelucchi","year":"2006","unstructured":"Pelucchi B, Aguiari G, Pignatelli A, et al. Nonspecific cation current associated with native polycystin-2 in HEK-293 cells. J Am Soc Nephrol. 2006;17:388\u201397.","journal-title":"J Am Soc Nephrol"},{"key":"1540_CR13","doi-asserted-by":"publisher","first-page":"7.23.1","DOI":"10.1002\/0471142735.im0723s111","volume":"111","author":"DB Kuhns","year":"2015","unstructured":"Kuhns DB, Long Priel DA, Chu J, Zarember KA. Isolation and functional analysis of human neutrophils. Curr Protoc Immunol. 2015;111:7.23.1\u20137.23.16.","journal-title":"Curr Protoc Immunol"},{"key":"1540_CR14","doi-asserted-by":"publisher","first-page":"F397","DOI":"10.1152\/ajprenal.00310.2002","volume":"285","author":"M Loghman-Adham","year":"2003","unstructured":"Loghman-Adham M, Nauli SM, Soto CE, Kariuki B, Zhou J. Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts. Am J Physiol Ren Physiol. 2003;285:F397\u2013412.","journal-title":"Am J Physiol Ren Physiol"},{"key":"1540_CR15","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1172\/JCI117770","volume":"95","author":"S Falzoni","year":"1995","unstructured":"Falzoni S, Munerati M, Ferrari D, Spisani S, Moretti S, Di Virgilio F. The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J Clin Invest. 1995;95:1207\u201316.","journal-title":"J Clin Invest"},{"key":"1540_CR16","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.1002\/jcp.26473","volume":"233","author":"L de Stephanis","year":"2018","unstructured":"de Stephanis L, Mangolini A, Servello M, et al. MicroRNA501-5p induces p53 proteasome degradation through the activation of the mTOR\/MDM2 pathway in ADPKD cells. J Cell Physiol. 2018;233:6911\u201324.","journal-title":"J Cell Physiol"},{"key":"1540_CR17","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1182\/blood-2009-12-260828","volume":"116","author":"S Gorini","year":"2010","unstructured":"Gorini S, Callegari G, Romagnoli G, et al. ATP secreted by endothelial cells blocks CX3 CL 1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y11 receptor activation. Blood. 2010;116:4492\u2013500.","journal-title":"Blood."},{"issue":"6","key":"1540_CR18","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1681\/ASN.2012070650","volume":"24","author":"E Cornec-Le Gall","year":"2013","unstructured":"Cornec-Le Gall E, Audr\u00e9zet MP, Chen JM, et al. Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol. 2013;24(6):1006\u201313.","journal-title":"J Am Soc Nephrol"},{"key":"1540_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ng1076","volume":"33","author":"SM Nauli","year":"2003","unstructured":"Nauli SM, Alenghat FJ, Luo Y, et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet. 2003;33:129\u201337.","journal-title":"Nat Genet"},{"key":"1540_CR20","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/35050128","volume":"408","author":"K Hanaoka","year":"2000","unstructured":"Hanaoka K, Qian F, Boletta A, et al. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature. 2000;408:990\u20134.","journal-title":"Nature."},{"key":"1540_CR21","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1113\/JP270933","volume":"594","author":"Y Yang","year":"2016","unstructured":"Yang Y, Ehrlich BE. Structural studies of the C-terminal tail of polycystin-2 (PC2) reveal insights into the mechanisms used for the functional regulation of PC2. J Physiol. 2016;594:4141\u20139.","journal-title":"J Physiol"},{"key":"1540_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.molimm.2014.07.005","volume":"63","author":"N Guo","year":"2015","unstructured":"Guo N, Zhang K, Lv M, Miao J, Chen Z, Zhu P. CD147 and CD98 complex-mediated homotypic aggregation attenuates the CypA-induced chemotactic effect on Jurkat T cells. Mol Immunol. 2015;63:253\u201363.","journal-title":"Mol Immunol"},{"key":"1540_CR23","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1189\/jlb.0303095","volume":"74","author":"E Layseca-Espinosa","year":"2003","unstructured":"Layseca-Espinosa E, Pedraza-Alva G, Montiel JL, del R\u00edo R, Fierro NA, Gonz\u00e1lez-Amaro R, Rosenstein Y. T cell aggregation induced through CD43: intracellular signals and inhibition by the immunomodulatory drug leflunomide. J Leukoc Biol. 2003;74:1083\u201393.","journal-title":"J Leukoc Biol"},{"key":"1540_CR24","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1172\/JCI80467","volume":"125","author":"L Chen","year":"2015","unstructured":"Chen L, Zhou X, Fan LX, et al. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease. J Clin Invest. 2015;125:2399\u2013412.","journal-title":"J Clin Invest"},{"key":"1540_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10157-016-1289-1","volume":"21","author":"L de Stephanis","year":"2017","unstructured":"de Stephanis L, Bonon A, Varani K, et al. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells. Clin Exp Nephrol. 2017;21:203\u201311.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"1540_CR26","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/mnfr.201400518","volume":"59","author":"S S\u00e1nchez-Fidalgo","year":"2015","unstructured":"S\u00e1nchez-Fidalgo S, Villegas I, Rosillo M\u00c1, et al. Dietary squalene supplementation improves DSS-induced acute colitis by downregulating p38 MAPK and NFkB signaling pathways. Mol Nutr Food Res. 2015;59(2):284\u201392.","journal-title":"Mol Nutr Food Res"},{"key":"1540_CR27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/978-3-319-51436-9_12","volume":"60","author":"CJ Song","year":"2017","unstructured":"Song CJ, Zimmerman KA, Henke SJ, Yoder BK. Inflammation and fibrosis in polycystic kidney disease. Results Probl Cell Differ. 2017;60:323\u201344.","journal-title":"Results Probl Cell Differ"},{"key":"1540_CR28","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1172\/JCI67273","volume":"124","author":"Y Cai","year":"2014","unstructured":"Cai Y, Fedeles SV, Dong K, et al. Altered trafficking and stability of polycystins underlie polycystic kidney disease. J Clin Invest. 2014;124:5129\u201344.","journal-title":"J Clin Invest"},{"key":"1540_CR29","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.kint.2015.11.015","volume":"89","author":"A Hofherr","year":"2016","unstructured":"Hofherr A, Wagner CJ, Watnick T, K\u00f6ttgen M. Targeted rescue of a polycystic kidney disease mutation by lysosomal inhibition. Kidney Int. 2016;89:949\u201355.","journal-title":"Kidney Int"},{"key":"1540_CR30","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1093\/hmg\/ddm383","volume":"17","author":"G Liang","year":"2008","unstructured":"Liang G, Li Q, Tang Y, et al. Polycystin-2 is regulated by endoplasmic reticulum-associated degradation. Hum Mol Genet. 2008;17:1109\u201319.","journal-title":"Hum Mol Genet"},{"key":"1540_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1365-2362.2007.01913.x","volume":"38","author":"GV Dedoussis","year":"2008","unstructured":"Dedoussis GV, Luo Y, Starremans P, et al. Co-inheritance of a PKD1 mutation and homozygous PKD2 variant: a potential modifier in autosomal dominant polycystic kidney disease. Eur J Clin Investig. 2008;38:180\u201390.","journal-title":"Eur J Clin Investig"},{"issue":"5","key":"1540_CR32","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1681\/ASN.2007010125","volume":"18","author":"S Rossetti","year":"2007","unstructured":"Rossetti S, Harris PC. Genotype-phenotype correlations in autosomal dominant and autosomal recessive polycystic kidney disease. J Am Soc Nephrol. 2007;18(5):1374\u201380.","journal-title":"J Am Soc Nephrol"},{"key":"1540_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.yexcr.2016.11.004","volume":"350","author":"XQ Dai","year":"2017","unstructured":"Dai XQ, Perez PL, Soria G, et al. External Ca<sup>2+<\/sup> regulates polycystin-2 (TRPP2) cation currents in LLC-PK1 renal epithelial cells. Exp Cell Res. 2017;350:50\u201361.","journal-title":"Exp Cell Res"},{"issue":"6","key":"1540_CR34","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1159\/000330080","volume":"27","author":"NG Santoso","year":"2011","unstructured":"Santoso NG, Cebotaru L, Guggino WB. Polycystin-1, 2, and STIM1 interact with IP(3) R to modulate ER ca release through the PI3K\/Akt pathway. Cell Physiol Biochem. 2011;27(6):715\u201326.","journal-title":"Cell Physiol Biochem"},{"issue":"24","key":"1540_CR35","doi-asserted-by":"publisher","first-page":"18794","DOI":"10.1074\/jbc.M109.090662","volume":"285","author":"E Sammels","year":"2010","unstructured":"Sammels E, Devogelaere B, Mekahli D, et al. Polycystin-2 activation by inositol 1,4,5-trisphosphate-induced Ca2+ release requires its direct association with the inositol 1,4,5-trisphosphate receptor in a signaling microdomain. J Biol Chem. 2010;285(24):18794\u2013805.","journal-title":"J Biol Chem"},{"issue":"7","key":"1540_CR36","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41581-019-0143-6","volume":"15","author":"Dominique Douguet","year":"2019","unstructured":"Douguet D, Patel A, Honor\u00e9 E. Structure and function of polycystins: insights into polycystic kidney disease. Nat Rev Nephrol. 2019. \n                    https:\/\/doi.org\/10.1038\/s41581-019-0143-6\n                    \n                   Review.","journal-title":"Nature Reviews Nephrology"},{"key":"1540_CR37","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/art.30203","volume":"63","author":"LL Santos","year":"2011","unstructured":"Santos LL, Fan H, Hall P, et al. Macrophage migration inhibitory factor regulates neutrophil chemotactic responses in inflammatory arthritis in mice. Arthritis Rheum. 2011;63:960\u201370.","journal-title":"Arthritis Rheum"},{"key":"1540_CR38","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1159\/000145463","volume":"109","author":"HY Lan","year":"2008","unstructured":"Lan HY. Role of macrophage migration inhibition factor in kidney disease. Nephron Exp Nephrol. 2008;109:e79\u201383.","journal-title":"Nephron Exp Nephrol"},{"key":"1540_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2215\/CJN.04140510","volume":"6","author":"V Menon","year":"2011","unstructured":"Menon V, Rudym D, Chandra P, Miskulin D, Perrone R, Sarnak M. Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease. Clin J Am Soc Nephrol. 2011;6:7\u201313.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"1540_CR40","doi-asserted-by":"publisher","first-page":"7214","DOI":"10.1074\/jbc.M805890200","volume":"284","author":"EY Park","year":"2009","unstructured":"Park EY, Sung YH, Yang MH, Noh JY, Park SY, Lee TY, Yook YJ, Yoo KH, Roh KJ, Kim I, Hwang YH, Oh GT, Seong JK, Ahn C, Lee HW, Park JH. Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice. J Biol Chem. 2009;284(11):7214\u201322.","journal-title":"J Biol Chem"},{"key":"1540_CR41","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1093\/hmg\/ddu208","volume":"23","author":"K Ravichandran","year":"2014","unstructured":"Ravichandran K, Zafar I, He Z, et al. An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2. Hum Mol Genet. 2014;23:4919\u201331.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"1540_CR42","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.bbadis.2009.03.001","volume":"1792","author":"G Aguiari","year":"2009","unstructured":"Aguiari G, Varani K, Bogo M, et al. Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A (3) adenosine receptors in human renal cells: implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells. Biochim Biophys Acta. 2009;1792(6):531\u201340.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"1540_CR43","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2215\/CJN.05850518","volume":"13","author":"KL Nowak","year":"2018","unstructured":"Nowak KL, Wang W, Farmer-Bailey H, et al. Vascular dysfunction, oxidative stress, and inflammation in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2018;13(10):1493\u2013501.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1540-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1540-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1540-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T23:04:05Z","timestamp":1599865445000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1540-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,13]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1540"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1540-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,13]]},"assertion":[{"value":"4 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval was granted by the ethics committee \u201c<i>Comitato Etico Indipendente dell\u2019Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi\u201d,<\/i> committee\u2019s reference number 061\/2008\/O\/Tess<i>.<\/i> A written consent was collected for all individuals enrolled in the study. The written consent was also obtained and preserved from some old patients that during the study (a few years) are died.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"355"}}